Researchers at the University of Illinois Chicago have developed a groundbreaking way to engineer ribosomes, the cellular machines responsible for building proteins, to produce only one specific protein at a time. Their findings, published in the journal Nature, introduce a new tool in synthetic biology called Ribo-M. This system physically links a ribosome to a specific messenger RNA (mRNA) strand, which acts as a genetic blueprint for making a particular protein. Unlike natural ribosomes, which must search the cell for the right mRNA to produce any of the many proteins a cell needs, these engineered ribosomes always carry the instructions for a single protein and focus exclusively on making it. The development of Ribo-M required extensive experimentation. The team tested tens of thousands of ribosome variants and screened thousands of bacterial colonies to find a design that worked. Once they identified a successful version, they demonstrated that Ribo-M could produce several different proteins, including one that causes green fluorescence, a protein that makes bacteria resistant to antibiotics, and an enzyme that produces light. These results show that the system is versatile and can be adapted for various purposes. The researchers believe this new approach opens up exciting possibilities for protein engineering. By using specialized ribosomes, scientists could create proteins with unique properties not found in nature. For example, they could incorporate nonstandard amino acids, which are not typically used in natural proteins, to build more stable or functionally advanced proteins. However, the current version of Ribo-M is still a proof of concept. One researcher compared it to an early stage of innovation, saying it is more like a "bicycle with wings" than a fully developed system. In the future, Ribo-M could be used to produce peptide-based medicines more efficiently. For instance, semaglutide, a drug used to treat diabetes and obesity, is currently manufactured through complex and costly processes. If specialized ribosomes could be engineered to produce such molecules inside cells, it could lead to a scalable and more efficient way to make designer drugs, enzymes, and other proteins. Beyond its potential medical applications, the study may also help scientists understand the origins of life. The engineered ribosome combines protein-making machinery with genetic instructions in a single unit, which could offer insights into how the first protein-making systems on Earth might have functioned. Before cells evolved to contain many free-floating ribosomes and mRNAs, such a unified system may have been essential for early life. The research was conducted by a team from the University of Illinois Chicago, including Kasra Alizadeh, Alexander Mankin, Dorota Klepacki, and Nora Vázquez-Laslop.